StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)

Close on Nov 18, 2026Market cap $24.97MP/E –Yield –

LeonaBio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

LeonaBio's price to book ratio was 1.1× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.2× to 3.5×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−0.0
2025Dec 31, 20251.1×+0.7
2024Dec 31, 20240.4×−0.2
2023Dec 29, 20230.6×+0.1
2022Dec 30, 20220.5×−1.0
2021Dec 31, 20211.4×−2.7
2020Dec 31, 20204.1×–

More LeonaBio figures

See a number that looks wrong?